Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Long-Term Debt Repayments (2021)

Vivos Therapeutics' Long-Term Debt Repayments history spans 1 years, with the latest figure at $25000.0 for Q1 2021.

  • Quarterly results put Long-Term Debt Repayments at $25000.0 for Q1 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $25000.0 (changed N/A YoY), and the annual figure for FY2021 was $25000.0, down 66.67%.
  • Long-Term Debt Repayments for Q1 2021 was $25000.0 at Vivos Therapeutics.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $25000.0 in Q1 2021 to a low of $25000.0 in Q1 2021.